184 related articles for article (PubMed ID: 26111150)
1. Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.
Anthony EG; Richard E; Lipkowitz MS; Bhatnagar V
Pharmacogenet Genomics; 2015 Sep; 25(9):444-9. PubMed ID: 26111150
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
Bhatnagar V; O'Connor DT; Schork NJ; Salem RM; Nievergelt CM; Rana BK; Smith DW; Bakris GL; Middleton JP; Norris KC; Wright JT; Cheek D; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS
J Hypertens; 2007 Oct; 25(10):2082-92. PubMed ID: 17885551
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
[TBL] [Abstract][Full Text] [Related]
4. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
Gupta S; Chattopadhyaya I; Agrawal BK; Sehajpal PK; Goel RK
J Postgrad Med; 2015; 61(1):21-6. PubMed ID: 25511213
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.
Bhatnagar V; Garcia EP; O'Connor DT; Brophy VH; Alcaraz J; Richard E; Bakris GL; Middleton JP; Norris KC; Wright J; Hiremath L; Contreras G; Appel LJ; Lipkowitz MS;
Am J Nephrol; 2010; 31(2):95-103. PubMed ID: 19907160
[TBL] [Abstract][Full Text] [Related]
6. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
Dai S; Ma W; Qin G; Wang L; Wang E
Clin Ther; 2021 Feb; 43(2):349-359.e2. PubMed ID: 33451866
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians.
Moran A; Simon JA; Shiboski S; Pickering TG; Waters D; Rotter JI; Lyon C; Nickerson D; Yang H; Saad M; Hsueh W; Krauss RM
Am J Hypertens; 2007 Aug; 20(8):884-91. PubMed ID: 17679038
[TBL] [Abstract][Full Text] [Related]
8. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
9. Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.
Juraschek SP; Appel LJ; Miller ER
Am J Hypertens; 2017 Sep; 30(9):871-875. PubMed ID: 28830083
[TBL] [Abstract][Full Text] [Related]
10. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
[TBL] [Abstract][Full Text] [Related]
11. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
[TBL] [Abstract][Full Text] [Related]
12. The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.
Jekell A; Kalani M; Kahan T
Heart Vessels; 2017 Jun; 32(6):674-684. PubMed ID: 27885499
[TBL] [Abstract][Full Text] [Related]
13. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
14. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
[TBL] [Abstract][Full Text] [Related]
15. The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?
Sica DA
J Clin Hypertens (Greenwich); 2003; 5(2):159-67. PubMed ID: 12671332
[TBL] [Abstract][Full Text] [Related]
16. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Poirier L; de Champlain J; Larochelle P; Lamarre-Cliche M; Lacourcière Y
Blood Press Monit; 2004 Oct; 9(5):231-6. PubMed ID: 15472494
[TBL] [Abstract][Full Text] [Related]
18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
20. Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors.
Yu HM; Lin SG; Liu GZ; Zhang YQ; Ma WJ; Deng CY
Clin Pharmacol Ther; 2006 Jun; 79(6):581-9. PubMed ID: 16765146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
